Acutus Medical, Inc. Provides Sales Guidance for the Year 2021
November 11, 2021 at 04:01 pm EST
Share
Acutus Medical, Inc. provided sales guidance for the year 2021. For the year, taking into consideration year-to-date results, external factors, and business performance, management now projects sales to be in the range of $17.0 million to $17.5 million.
Acutus Medical, Inc. is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. (Medtronic). The Company is solely focused on supporting the manufacturing and distribution of products to Medtronic. It manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or steerable introducers, and steerable sheaths (Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic include versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.